IDiyas

For the Inventor, By the Inventor

Barcelona, Spain

Maria Rosa Cuberes-Altisent

USPTO Granted Patents = 15

 


Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 55(Granted Patents)


Location History:

  • Sant Cugat del Valles, ES (1997)
  • Cugat de Vallés, ES (2010)
  • S. Cugat de Vallés, ES (2012)
  • Barcelona, ES (1992 - 2013)
  • San Cugat del Valles, ES (2017)

Company Filing History:

goldMedal13 out of 150 
 
Laboratorios Del Dr. Esteve S.a.
 patents
silverMedal2 out of 23 
 
Laboratories Del Dr. Esteve S.a.
 patents

Years Active: 1992-2017

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 9567338 - [object Object] (2017-02-14),
2. 8492425 - 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles useful as sigma receptor inhibitors (2013-07-23),
3. 8394797 - Substituted pyrazole sigma receptor antagonists (2013-03-12),
4. 8349878 - 1,2,4-triazole derivatives as sigma receptor inhibitors (2013-01-08),
5. 8329880 - Process for the preparation of naphthalen-2-yl-pyrazol-3-one intermediates useful in the synthesis of sigma receptor inhibitors (2012-12-11),
6. 8314096 - Sigma receptor inhibitors (2012-11-20),
7. 8293740 - Sigma receptor inhibitors (2012-10-23),
8. 8193223 - 1,2,3-triazole derivatives as sigma receptor inhibitors (2012-06-05),
9. 8039497 - 1,2,4-triazole derivatives as sigma receptor inhibitors (2011-10-18),
10. 7829559 - Substituted pyrazole sigma receptor antagonists (2010-11-09),
11. RE38963 - Pyrazoline derivatives, their preparation and application as medicaments (2006-01-30),
12. 5641781 - Topical ophthalmic composition comprising a (1997-06-24),
13. 5214040 - Nonsaditive antihistaminics derived from benzimidazoles (1993-05-25),
14. 5182280 - Derivatives of benzimidazole and their use as antihistamines (1993-01-26),
15. 5166205 - Derivatives of 1-diphenylmethyl piperazine and their use as (1992-11-24),

Title: Maria Rosa Cuberes-Altisent: Pioneering Innovator in Medicinal Chemistry

Introduction: Maria Rosa Cuberes-Altisent is a renowned inventor based in Barcelona, Spain, who has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 15 patents, her work primarily focuses on developing innovative compounds for therapeutic applications.

Latest Patents: Among her latest intellectual properties are the pyrazolo[3,4-d]pyrimidine compounds that demonstrate a strong affinity for sigma receptors, particularly sigma-1 receptors. These innovative compounds are essential in formulating medicaments aimed at treating various diseases. Her work includes the general formula (I): 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles, which act as sigma receptor inhibitors. The invention also elaborates on the processes for preparing these compounds, their compositions, and their therapeutic uses against sigma receptor-mediated conditions.

Career Highlights: Over her illustrious career, Maria Rosa Cuberes-Altisent has worked with respected institutions such as Laboratorios del Dr. Esteve S.A. This collaboration has enabled her to push forward the boundaries of medicinal chemistry and contribute notable advancements in drug development.

Collaborations: Maria Rosa has collaborated with esteemed colleagues such as Jordi Frigola-Constansa and Joerg Holenz. Their joint efforts enhance the research and innovation landscape, fostering the development of critical therapeutic solutions.

Conclusion: Maria Rosa Cuberes-Altisent exemplifies the spirit of innovation and dedication within the field of medicinal chemistry. Her numerous patents and collaborative work underline her commitment to advancing healthcare solutions, thus making her a significant figure in the world of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…